RIPK1 and colorectal carcinoma: The use of FMR1 anti transcription therapy in CRC cell lines will upregulate RIPK1 and cause necrotic apoptosis of CRC cells.313 In conclusion, the susceptibility to necrotic apoptosis inducers may be of great significance for the clinical treatment of colorectal tumors.